At most law schools, you’ll find student groups laser-focused on bar practice exams and clinic internships. But earlier this ...
In a new trial, the Bruton tyrosine kinase (BTK) inhibitor pirtobrutinib increased the rate of survival without disease progression and was well tolerated with a more favorable safety profile when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results